Labriola
Blaise F. Labriola, Park City, UT US
Patent application number | Description | Published |
---|---|---|
20150235242 | SYSTEM AND METHOD FOR INTERACTIVE FORECASTING, NEWS, AND DATA ON RISK PORTFOLIO WEBSITE - A system receives public opinion information and then generates statistical output based upon the received information. Users access the system and enter their opinions or projections with respect to a particular subject. The system utilizes the entered information to provide users with public opinion and projection data. The amount of weight that any particular opinion is given depends upon the time that the opinion was submitted. | 08-20-2015 |
Leticia Labriola, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20140113347 | Biopolymer Composition for Encapsulating Cells, Method for Producing a Biopolymer Composition for Encapsulating Cells, Method for Promoting Cell Cytoprotection and Use of a Biopolymer Composition for Encapsulating Cells - The present invention relates to a biopolymer composition for encapsulating cells, containing alginate, at least one glycosaminoglycan compound, preferably chondroitin sulfate, and at least one component of the extracellular matrix, preferably laminin, and to the process for producing the biopolymer composition. Also disclosed are a method for promoting cytoprotection using this composition, and the use of this composition for preparing a medicament useful in cell transplantation. | 04-24-2014 |
Rafael A. Labriola, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20100197935 | CRYSTALLINE FORM OF THE ZOLEDRONIC ACID, A PROCESS TO OBTAIN IT AND THE PHARMACEUTICAL COMPOSITION COMPRISING IT - A method to obtain a new crystalline form of the Zoledronic acid, characterized by its X-rays diffractogram as well as by its spatial atomic distribution in the red crystalline and its curves of thermal analysis. There is also included a method to obtain this crystalline form, which includes the synthesis of the corresponding acid and the pharmaceutical composition this crystalline form comprises. | 08-05-2010 |
Rafael Alberto Labriola, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20100197931 | CRYSTALLINE FORM OF THE ZOLEDRONIC ACID, A PROCESS TO OBTAIN IT AND THE PHARMACEUTICAL COMPOSITION COMPRISING IT - A new crystalline form of the Zoledronic acid, characterized by its X-rays diffractogram as well as by its spatial atomic distribution in the red crystalline and its curves of thermal analysis. There is also included a method to obtain this crystalline form, which includes the synthesis of the corresponding acid and the pharmaceutical composition this crystalline form comprises. | 08-05-2010 |
Rafael Alberto Labriola, Beccar AR
Patent application number | Description | Published |
---|---|---|
20090203724 | SOLID AND CRYSTALLINE DUTASTERIDE AND PROCESSES FOR PREPARATION THEREOF - The solid state chemistry of 17β-N-[2,5-bis(trifluoromethyl)phenyl]carbamoyl-4-aza-5-α-androst-1-en-3-one of which the international nonproprietary name is Dutasteride (the active ingredient in products marketed as Avodart, Avidart, Avolve, Duagen, Dutas, Dutagen, Duprost) and its process for preparing. The synthetic process comprises formation of the mixed anhydride, its subsequent reaction with 2,5-bis(trifluoromethyl)phenylamine in the presence of an appropriate Lewis catalyst and its isolation, purification and crystallization from acetonitrile/water. | 08-13-2009 |